Meningitis outbreak trial: Potentially deadly bacteria found in NECC drugs
BOSTON — Microbiologists from the U.S. Food and Drug Administration testified Thursday that they found mold, yeast and bacteria, some of it potentially deadly, in several drugs shipped from a Massachusetts drug compounder.
The FDA scientists, testifying in the trial of one-time supervising pharmacist Glenn Chin, said that a variety of bacteria were found in...
Long lists of prescription drug side effects can confuse consumers: study
Side effects may include confusion and irritability.
Marketers for direct-to-consumer medication often trick consumers, downplaying the risks of drugs by presenting too many possible dangers simultaneously, according to a study.
The research, conducted by a team at the University of Michigan and published in the journal Nature Human Behaviour, reveals that when a drug advertisement throws...
Collierville man awarded $140 million in lawsuit over testosterone drug AndroGel
A Collierville man has been awarded more than $140 million in a lawsuit against the makers of a testosterone drug that he says caused him to have a heart attack.
A federal court jury in Chicago handed down the verdict in favor of Jeffrey Konrad on Thursday after several weeks of testimony in which his...
Outrage Over Accusations That Pharmaceutical Company Created ‘Fake’ Cancer Patients
Corporations have a responsibility to their customers and the public to be ethical, honest, and forthright.
But that obligation is heightened to a degree for pharmaceutical firms, especially the ones whose customers are dealing with serious illness or acute, chronic pain.
Insys Therapeutics deals with both types of patients.
The Arizona-based drug company got approval five years...
Tracking costs from recalled medical devices
The billions of dollars that Medicare has spent on recalled or defective medical devices are a “significant cause for concern,” yet the government lacks a reliable way to track such spending a decade after it emerged as a sore point, auditors concluded this week.
The U.S. Health and Human Services inspector general’s office issued a...
Chesco pharma giant fined $260M in scheme that put cancer patients at risk
One of the largest distributors of pharmaceuticals in the United States, the Valley Forge-headquartered AmerisourceBergen Corp., will pay $260 million in penalties after pleading guilty in a subsidiary’s scheme that put the health of thousands of cancer patients at risk.
AmerisourceBergen Specialty Group operated divisions in Alabama — Medical Initiatives Inc. and Oncology Supply Co....
Key employment dispute leaves Supreme Court divided
WASHINGTON (Reuters) - Liberal U.S. Supreme Court justices on Monday defended the right of workers to bring class-action claims against companies but their conservative counterparts who are in the majority sounded skeptical in the biggest business case of the court’s new term.
A win for employers would give the green-light to an already growing trend...
Supreme Court won’t settle split over damages for age bias
The U.S. Supreme Court on Monday declined to wade into a circuit split over whether plaintiffs suing for age discrimination or retaliation can reap damages for pain and suffering.
The court denied certiorari to Susan Vaughan, a former nurse supervisor at Anderson Regional Medical Center in Mississippi who had argued that amendments to the Fair...
Government seeks $73m for victims of 2012 meningitis outbreak
Barry J. Cadden, owner of the now-defunct Framingham compounding pharmacy that was responsible for a deadly meningitis outbreak five years ago, should pay $73.7 million in restitution to the victims, federal prosecutors say.
Cadden was convicted in March of running a criminal enterprise — the New England Compounding Center — that mailed thousands of drugs...
Drug company subsidiary admits shipping misbranded cancer medicine from unregistered facility for 13 years
A subsidiary for one of the country’s biggest wholesale drug companies admitted Wednesday in Brooklyn Federal Court to distributing misbranded drugs related to cancer treatment.
AmerisourceBergen Specialty Group pleaded guilty to the illegal distribution of misbranded drugs in connection to its nationwide shipments coming from an Alabama-based facility that wasn’t registered with the Food and...
